Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.

Swerdlow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JK, Sander B, Ott G, Xerri L, Quintanilla-Martinez L, Campo E.

Virchows Arch. 2016 Mar;468(3):259-75. doi: 10.1007/s00428-015-1858-9. Epub 2015 Oct 10. Review.

2.

Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis.

Cao X, Ye Q, Orlowski RZ, Wang X, Loghavi S, Tu M, Thomas SK, Shan J, Li S, Qazilbash M, Yin CC, Weber D, Miranda RN, Xu-Monette ZY, Medeiros LJ, Young KH.

J Hematol Oncol. 2015 Jun 24;8:74. doi: 10.1186/s13045-015-0172-y.

3.

Lymphoplasmacytic non-Hodgkin lymphoma/Waldenström's macroglobulinemia with CD5+, CD23+, and CD10-.

D'Angelo G, Hotz AM, Monti M.

Blood Res. 2013 Dec;48(4):300-3. doi: 10.5045/br.2013.48.4.300. Epub 2013 Dec 24. No abstract available.

4.

Novel treatment options for Waldenström macroglobulinemia.

Leblebjian H, Agarwal A, Ghobrial I.

Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2:S310-6. doi: 10.1016/j.clml.2013.05.023. Review.

5.

Genetic factors and pathogenesis of Waldenström's macroglobulinemia.

Monge J, Braggio E, Ansell SM.

Curr Oncol Rep. 2013 Oct;15(5):450-6. doi: 10.1007/s11912-013-0331-7. Review.

6.

Molecular pathogenesis of Waldenstrom's macroglobulinemia.

Braggio E, Philipsborn C, Novak A, Hodge L, Ansell S, Fonseca R.

Haematologica. 2012 Sep;97(9):1281-90. doi: 10.3324/haematol.2012.068478. Epub 2012 Jul 6. Review.

7.

Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families.

McMaster ML, Goldin LR, Bai Y, Ter-Minassian M, Boehringer S, Giambarresi TR, Vasquez LG, Tucker MA.

Am J Hum Genet. 2006 Oct;79(4):695-701. Epub 2006 Aug 31.

8.

Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.

Chng WJ, Schop RF, Price-Troska T, Ghobrial I, Kay N, Jelinek DF, Gertz MA, Dispenzieri A, Lacy M, Kyle RA, Greipp PR, Tschumper RC, Fonseca R, Bergsagel PL.

Blood. 2006 Oct 15;108(8):2755-63. Epub 2006 Jun 27.

9.

Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.

George TI, Wrede JE, Bangs CD, Cherry AM, Warnke RA, Arber DA.

J Mol Diagn. 2005 Aug;7(3):346-51.

Supplemental Content

Support Center